Polycythemia Vera Thrombosis Risk

ورودی‌های بالینی بیمار

حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
risk flag
—flag
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

Direct Clinical Answer

The Polycythemia Vera Thrombosis Risk calculates determining thromboembolic risk, heparin-induced thrombocytopenia probability, and bleeding diathesis. Key inputs include age. Scores guide initiating targeted anticoagulation therapy, platelet monitoring, or hematology specialist referral. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

ELN/Tefferi risk stratification for thrombosis in polycythemia vera: high risk if age >= 60 or prior thrombosis.

Clinical Indication

The Polycythemia Vera Thrombosis Risk is indicated for bedside clinical practice to support ELN/Tefferi risk stratification for thrombosis in polycythemia vera: high risk if age >= 60 or prior thrombosis.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.

Limitations & Contraindications

Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention.

Clinical Pearls & Action Plan

Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies. Guideline pearl: High-risk PV: cytoreductive therapy (hydroxyurea) plus low-dose aspirin recommended.

Formula & Variables:

High risk = age >= 60 years OR history of thrombosis

Input Parameters

NameTypeRequiredDescription
ageintegerYesAge in years(years)
prior_thrombosisbooleanYesHistory of arterial or venous thrombosis

Evidence-Based References (EBM)

  • Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management. Am J Hematol. 2020;95(12):1599-1613.

Related calculators